Although CD155 has the best affinity for TIGIT and tends to immunosuppress and reduce the activity of TIGIT expressing NK and T cells in the tumor microenvironment, the sensitivity of tumor cells to NK cell-mediated cytotoxicity is not only regulated by CD155/TIGIT [17–19]. Here, TIGIT is linked to neoplasm.